Inspire Medical Systems (NYSE:INSP) Stock Price Breaks Below 200 Day Moving Average - Here's Why

Inspire Medical Systems logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Inspire Medical Systems shares fell below their 200-day moving average, trading as low as $55.54 against a $57.31 average and last quoted at $56.51.
  • Analyst views are mixed: the consensus rating is Hold, with a $71.24 average price target; ratings range from Sell to Strong Buy.
  • The company beat quarterly EPS and revenue estimates, reporting $0.14 per share and $206.69 million in revenue, though revenue declined 7.9% year over year.
  • MarketBeat previews the top five stocks to own by December 1st.

Inspire Medical Systems, Inc. (NYSE:INSP - Get Free Report) shares crossed below its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of $57.31 and traded as low as $55.54. Inspire Medical Systems shares last traded at $56.5140, with a volume of 614,737 shares.

Analyst Ratings Changes

INSP has been the topic of several analyst reports. KeyCorp reiterated a "sector weight" rating on shares of Inspire Medical Systems in a report on Tuesday, August 4th. Weiss Ratings cut shares of Inspire Medical Systems from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Thursday, November 12th. Oppenheimer raised Inspire Medical Systems from a "market perform" rating to an "outperform" rating and set a $85.00 price objective for the company in a research report on Tuesday, August 4th. Piper Sandler upped their price target on Inspire Medical Systems from $60.00 to $70.00 and gave the stock a "neutral" rating in a research note on Tuesday, November 3rd. Finally, Stifel Nicolaus raised their price objective on shares of Inspire Medical Systems from $75.00 to $80.00 and gave the company a "buy" rating in a research note on Friday, September 11th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, twelve have assigned a Hold rating and four have given a Sell rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $71.24.

Get Our Latest Analysis on INSP

Inspire Medical Systems Stock Performance

The stock has a 50-day moving average price of $68.41 and a two-hundred day moving average price of $57.31. The stock has a market capitalization of $1.64 billion, a PE ratio of 16.43, a PEG ratio of 4.25 and a beta of 0.67.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last announced its quarterly earnings data on Monday, November 2nd. The company reported $0.14 EPS for the quarter, beating the consensus estimate of $0.09 by $0.05. The business had revenue of $206.69 million for the quarter, compared to the consensus estimate of $204.31 million. Inspire Medical Systems had a return on equity of 7.32% and a net margin of 11.43%. The business's revenue was down 7.9% on a year-over-year basis. During the same period in the previous year, the business earned $0.38 earnings per share. As a group, equities analysts predict that Inspire Medical Systems, Inc. will post 1.29 earnings per share for the current year.

Institutional Trading of Inspire Medical Systems

Several hedge funds have recently modified their holdings of the company. EverSource Wealth Advisors LLC increased its holdings in shares of Inspire Medical Systems by 1,115.4% in the 1st quarter. EverSource Wealth Advisors LLC now owns 632 shares of the company's stock worth $33,000 after buying an additional 580 shares during the last quarter. Versant Capital Management Inc lifted its holdings in shares of Inspire Medical Systems by 379.0% in the 2nd quarter. Versant Capital Management Inc now owns 958 shares of the company's stock valued at $43,000 after acquiring an additional 758 shares during the last quarter. GAMMA Investing LLC lifted its holdings in shares of Inspire Medical Systems by 85.0% in the 2nd quarter. GAMMA Investing LLC now owns 1,221 shares of the company's stock valued at $54,000 after acquiring an additional 561 shares during the last quarter. Sterling Capital Management LLC grew its position in Inspire Medical Systems by 450.6% in the third quarter. Sterling Capital Management LLC now owns 914 shares of the company's stock worth $63,000 after acquiring an additional 748 shares in the last quarter. Finally, State of Wyoming grew its position in Inspire Medical Systems by 83.7% in the first quarter. State of Wyoming now owns 1,343 shares of the company's stock worth $69,000 after acquiring an additional 612 shares in the last quarter. 94.91% of the stock is owned by hedge funds and other institutional investors.

Inspire Medical Systems Company Profile

(Get Free Report)

Inspire Medical Systems is a medical technology company focused on treatments for obstructive sleep apnea, a condition in which breathing repeatedly stops or becomes restricted during sleep. Founded in 2007 and based in Minnesota, the company develops implantable devices intended for certain patients who cannot use or benefit from conventional positive airway pressure therapy. Its primary product, the Inspire Upper Airway Stimulation system, uses an implanted device to monitor breathing and deliver mild stimulation to the hypoglossal nerve, helping keep the airway open during sleep.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Inspire Medical Systems Right Now?

Before you consider Inspire Medical Systems, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Inspire Medical Systems wasn't on the list.

While Inspire Medical Systems currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines